Glycopegylated Granulocyte Colony Stimulating Factor

Details for Australian Patent Application No. 2006203792 (hide)

International Classifications

Event Publications

2 August 2007 PCT application entered the National Phase

PCT publication WO2006/074467 Priority application(s): WO2006/074467

23 October 2008 Amendment Made

The nature of the amendment is: Amend the priority details to read from 11/166,404 23 June 2005 US to 11/166,404 02 Nov 2005 US 2006237681 Neurotrophincell Pty Limited The nature of the amendment is: Amend the name of the inventor to include co-inventor Gorba, Thorsten

23 April 2009 Amendment Made

The nature of the amendment is: Amend the priority details to read 11/166,404 23 Jun 2005 US 2006252258 Verenium Corporation The nature of the amendment is: Add the priority details to read 60/254,414 07 Dec 2000 US; 60/309,006 30 Jul 2001 US; 60/351,336 22 Jan 2002 US; 60/300,189 21 Jun 2001 US and 60/173,609 29 Dec 1999 US 2006317689 Epix Delaware, Inc. The nature of the amendment is: Add the following co-inventors name Penland, Robert Christian and Gannon, Kimberley

23 April 2009 Assignment before Grant

Neose Technologies, Inc. The application has been assigned to BioGeneriX AG

3 November 2011 Application Accepted

Published as AU-B-2006203792

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.